Stress and the gut-brain connection
The gut-brain connection is no joke as it can link anxiety to stomach problems and vice versa. Have you ever had a gut-wrenching experience? Do certain situations make you feel nauseous? Have you ever felt butterflies in your stomach? We use these...
The gut-brain connection is no joke as it can link anxiety to stomach problems and vice versa. Have you ever had a gut-wrenching experience? Do certain situations make you feel nauseous? Have you ever felt butterflies in your stomach? We use these...
2 years 2 months ago
Health – Demerara Waves Online News- Guyana
High-tech diagnostic system among 2023 plans-Health Minister
Health Minister Dr Frank Anthony on Tuesday announced that Guyana’s health care professionals would soon be able conduct diagnosis remotely. He also told the National Assembly that 1,000 nurses would be trained this year and 1,000 Guyanese would receive hearing aids free of cost on top of the 500 that were provided with those devices ...
Health Minister Dr Frank Anthony on Tuesday announced that Guyana’s health care professionals would soon be able conduct diagnosis remotely. He also told the National Assembly that 1,000 nurses would be trained this year and 1,000 Guyanese would receive hearing aids free of cost on top of the 500 that were provided with those devices ...
2 years 2 months ago
Health, News, Politics
Exercising with others offers greater benefits to older people
Exercise is beneficial in obvious ways like getting a leaner and stronger body, yet its benefits can also improve the brain, including in older adults.
Exercise is beneficial in obvious ways like getting a leaner and stronger body, yet its benefits can also improve the brain, including in older adults.
2 years 2 months ago
Health Archives - Barbados Today
U.S. FDA proposes shift to annual COVID vaccine shots
SOURCE: Reuters – The U.S. health regulator on Monday proposed one dose of the latest updated COVID-19 shot annually for healthy adults, similar to the influenza immunization campaign, as it aims to simplify the country’s COVID-vaccine strategy.
The U.S. Food and Drug Administration also asked its panel of external advisers to consider the usage of two COVID vaccine shots a year for some young children, older adults and persons with compromised immunity. The regulator proposed the need for routine selection of variants for updating the vaccine, similar to the way strains for flu vaccines are changed annually, in briefing documents ahead of a meeting of its panel on Thursday.
The FDA hopes annual immunization schedules may contribute to less complicated vaccine deployment and fewer vaccine administration errors, leading to improved vaccine coverage rates. The agency’s proposal was on expected lines, following its announcement of its intention for the update last month.
The Biden administration has also been planning for a campaign of vaccine boosters every fall season.
Currently, most people in the United States need to first get two doses of the original COVID vaccine spaced at least three to four weeks apart, depending on the vaccine, followed by a booster dose a few months later.
Pfizer’s primary vaccine doses for children and people involve three shots, with the third a bivalent shot given about two months later.
If the panel votes in favor of the proposal, Pfizer Inc (PFE.N) and Moderna Inc’s (MRNA.O) bivalent vaccines, which target both the Omicron and the original variants, would be used for all COVID vaccine doses, and not just as boosters.
The post U.S. FDA proposes shift to annual COVID vaccine shots appeared first on Barbados Today.
2 years 2 months ago
A Slider, COVID-19, Health, United States, USA, World
PAHO/WHO | Pan American Health Organization
WHO launches funding appeal to help a record number of people in complex, intersecting health emergencies
WHO launches funding appeal to help a record number of people in complex, intersecting health emergencies
Cristina Mitchell
23 Jan 2023
WHO launches funding appeal to help a record number of people in complex, intersecting health emergencies
Cristina Mitchell
23 Jan 2023
2 years 2 months ago
Authorities close a water processing plant in Santo Domingo Este due to unsanitary conditions
The health authorities ordered the closure of a water processing and bottling plant for violating General Health Law 42-01 and its Public Health Regulation 258-01. Agua Los Charcos, formerly Agua Praxia, is located at kilometer 13 of the Mella Highway, in front of the Housing Park, in Santo Domingo Este.
This processor was closed because it lacked the corresponding health records issued by that vice-ministry.
Furthermore, pseudomonas, a type of bacteria that frequently causes severe infections in humans, was detected in the processed water tests, as well as unsanitary conditions and a lack of heating.
Concerning the cholera disease, the Ministry of Public Health advises the public not to be alarmed, to pay attention to official reports, and to practice preventative measures such as frequent hand washing and food washing.
2 years 2 months ago
Health, Local
PAHO/WHO | Pan American Health Organization
Five billion people unprotected from trans fat leading to heart disease
Five billion people unprotected from trans fat leading to heart disease
Cristina Mitchell
23 Jan 2023
Five billion people unprotected from trans fat leading to heart disease
Cristina Mitchell
23 Jan 2023
2 years 2 months ago
Dangers of consuming excessive amounts of added sugar
“A 16-ounce or 473-ml can of soda contains 52 grams or 13 teaspoons of sugar, which is more than 10% of your daily calorie consumption, based on a 2,000-calorie diet”
View the full post Dangers of consuming excessive amounts of added sugar on NOW Grenada.
2 years 2 months ago
Health, PRESS RELEASE, gfnc, grenada food & nutrition council, Obesity, sugar
Medical News, Health News Latest, Medical News Today - Medical Dialogues |
DME Gujarat Announces Vacant Seat Details After Day 1 Of 6th Offline Round For UG AYUSH admissions
Gujarat: 6th offline round of UG AYUSH (BAMS, BHMS) courses is being carried out. After day 1 of the counseling process held on 21.1.2023, 1350 seats are left vacant. The Director of Medical Education (DME Gujarat) has announced this through a written notice. The date-wise and institute-wise admission of the student list has also been released.
As per the notice, BAMS has 725 seats, and BHMS has 625 seats left vacant. The counseling will be carried out till 24.1.2023. No proxy and authority are allowed in this round, so candidates must come in person per their merit numbers' schedule. They must reach the selected help center 30 minutes before the scheduled time for counseling.
All the candidates who are included in the merit list of ACPUGMEC can participate in the 6th offline round, except the candidates who have secured and joined admission in MBBS & BDS courses in previous rounds of Medical Counseling Committee (MCC)/Previous rounds of State Quota OR except the candidates, who have secured and joined admission in BAMS OR BHMS courses through AACCC, New Delhi.
Date-wise and institute-wise admission of student list –
The following are the colleges where students have been allotted seats -
1. Government Akhandanand Ayurveda College Ahmedabad
2. Netra Chikitsa Ayurved College Amreli
3. Government Ayurveda College Vadodara
4. Sheth J.P. Government Ayurved College Bhavnagar
5. Dhruv institute of Ayurved People's Welfare Society Vrajbhumi Ashram At-Dumiyani Tal-Upleta Dist-Rajkot-360440 Gujarat
6. Monark Ayurved Medical College & Hospital AT.& Post- Vahelal Naroda- Dahegam Road Ta. Dascroi Ahmedabad
7. Gokul Ayurvedic College Siddhpur
8. Noble Ayurved College and Research Institute Bamangam Junagadh
9. Government Ayurved College Junagadh
10. Aarihant Ayurvedic Medical College And Research Institute Adalaj Gandhinagar
11. K J Institute of Ayurveda and Research Savli Vadodara
12. Dhanvantari Ayurved College Koydam Dist. Mahisagar
13. Shree Swaminarayan Ayurvedic College Kalol
14. Murlidhar Ayurved College Kalipat Rajkot
15. Merchant Ayurved College At & post Basna Ta- Visnagar Dist. Mehsana
16. J. S. Ayurveda Mahavidyalaya Nadiad
17. S. S. Agrawal Institute of Ayurveda, Viranjali marg, Gandevi road, Navsari-396445, Gujarat
18. Parul Institute of Ayurved and Research Limda Waghodia Vadodara
19. Jay Jalram Ayurvedic Medical College Shivpuri Dist. Panchamahals
20. Manjushree Research Institute of Ayurvedic Science Piplaj Dist. Gandhinagar
21. Parul Institute of Ayurved Limda Waghodia Vadodara
22. B.G. Garaiya Ayurved College Kalipat Dist. Rajkot
23. Global Institute of Ayurveda Tramba (Kasturbadham) Rajkot
24. Shree Rasiklal Manikchandji Dhariwal Ayurved College & Hospital Waghaldhara Valsad
25. RK University Ayurvedic College & Hospital Kasturbadham Rajkot
26. Shri O. H. Nazar Ayurved College Surat
27. State Model Institute of Ayurveda Sciences Kolavada Gandhianagar
28. G.J. Patel Institute of Ayurvedic Studies And Research Vallabh Vidyanagar Anand
29. Shri V M Mehta Institute of Ayurved Gardi Vidhyapith Campus Kalawad Road Rajkot
30. Dr.Vasant Parikh Ayurvedic Medical College Vadnagar
31. Ahmedabad Homoeopathic Medical College Ahmedabad
32. Smt. Vasantben N. Vyas Homoeopathic Medical College Jesingpara Amreli
33. Anand Homeopathic Medical College & Research Insitute Anand
34. Dr. V. H. Dave Homoeopathic Medical College Anand
35. Laxmiben Homoeopathy Institute & Research Center At Bhandu Dist. Mehsana
36. Shree Mahalaxmiji Mahila Homoeopathic Medical College & Hospital Vadodara
37. Pioneer (M.S.Pathak) Homoeopathic Medical College & Hospital Vadodara
38. Baroda Homoeopathic Medical College Vadodara
39. Bhargava Homoeopathic Medical College Vidyagram Dist. Anand
40. Government Homoeopathic Medical College and Hospital Dethali Dist. Patan
41. Shree Shamalaji Homoeopathic Medical College Godhra
42. Shree H. N. Shukla Homoeopathic Medical College & Hospital Amargadh (Bhikhari) Rajkot
43. Jay Jalaram Homoeopathic Medical College & Hospital At Morva (Rena) Dist: Panchamahal
44. Jawaharlal Nehru Homoeopathic Medical College Post: Limda Dist: Vadodara
45. Aarihant Homoeopathic Medical College and Research Institute Opp. IFFCO Adalaj Kalol Highway Gandhinagar
46. Smt Malini Kishore Sanghvi Homoeopathic Medical College Miyagam Karjan Dist: Vadodara
47. Valan Homeopathic Medical College and Hospital
48. Lalitaben Ramniklal Shah Homoeopathy College At Anandpar Dis.Jamnagar
49. Shri Aryatej Homoeopathic Medical College Aryavart Near Navyug Tiles Nr. Laxminagar Village 8-A National Highway Laxminagar Morbi Gujarat
50. Gandhinagar Homoeopathic Medical College At Mubarakpur Dist.Gandhinagar
51. Smt. AJ savla Homoeopathic Medical College Mehsana
52. Merchant Homoeopathic Medical College & Hospital Basna Dist: Mehsana
53. Noble Homoeopathic College & Research Institute Bamangam Dist: Junagadh
54. Parul Institute Of Homoeopathy and Research Post. Limda Dist. Vadodara
55. Shri B G Garaiya Homoeopathic Medical College Kalipat Dist. Rajkot
56. Rajkot Homoeopathic Medical College Gondal Road Rajko
57. Kamdar Homeopathic Medical College & Research Centre Rajkot
58. Arrdekta Homoeopathic Medical College & Hospital Navi Metral Sabarkantha
59. Gujarat Homoeopathic Medical College & Hospital Savli Dist. Vadodara
60. Gokul Homoeopathy Medical College Gokul Foundation Opp. IOC Depot State Highway No. 41 Sujanpur Patia Dist. Patan Gujarat
61. Shri Sardar Patel Mahila Homeopathic Medical College, Rajkot
62. S.S.Agrawal Homoeopathic Medical College & General Hospital Navsari
63. C.N.Kothari Homoeopathic Medical College And Research Centre Vyara Dist: Tapi
64. Nootan Homeopathic Medical College & Hospital Visnagar
The detailed list is enclosed in the notice below.
To view the notice, click on the links below –
https://medicaldialogues.in/pdf_upload/datewiseday1-199315.pdf
2 years 2 months ago
AYUSH,State News,News,Gujarat,Ayurveda,Homeopathy,Medical Education,Ayush Education News,Latest Medical Education News
Ministry of Public Health reports six new cases of cholera
The Ministry of Public Health and Social Assistance (Mispas), through the Vice Ministry of Collective Health and its General Directorate of Epidemiology (Digepi), reported six new cases of cholera on Sunday, two of which were Dominicans, a 56-year-old male and a 37-year-old female, living in Villa Liberación and the Solares del Almirante in Santo Domingo Este.
The remaining four cases are imported and pertain to Haitian nationals, two men aged 47 and 31, a woman aged 72, and a 9-year-old girl.
There are 31 confirmed positive cases of the disease in the country, in addition to these six. The patients were admitted between January 18 and 20, according to a press release, after presenting with whitish watery diarrhea and vomiting. “When they were treated at the health center, they were hydrated and stabilized before proceeding immediately to take stool samples, which turned out to be positive for cholera this Sunday,” according to the Ministry of Health.
He adds that the medical report confirms that the patients have been without bowel movements for more than 24 hours, that they are stable and in good spirits, and that they will be discharged in the next few hours.
2 years 2 months ago
Health, Local
Woman pleads for Utahns to get HPV vaccine to prevent cervical cancer - KSL.com
- Woman pleads for Utahns to get HPV vaccine to prevent cervical cancer KSL.com
- Cervical Cancer Awareness: Here’s how unprotected sex can cause cervical cancer Health shots
- Cervical Cancer: How Unprotected Sex Can Increase The Risk? All You Need to Know India.com
- Can HPV Vaccine Prevent Cervical Cancer: Current Studies (Part 3) The Epoch Times
- How telemedicine can aid the fight against cervical cancer Jamaica Observer
2 years 2 months ago
Woman pleads for Utahns to get HPV vaccine to prevent cervical cancer - KSL.com
- Woman pleads for Utahns to get HPV vaccine to prevent cervical cancer KSL.com
- Cervical Cancer Awareness: Here’s how unprotected sex can cause cervical cancer Health shots
- Can HPV Vaccine Prevent Cervical Cancer: Current Studies (Part 3) The Epoch Times
- How telemedicine can aid the fight against cervical cancer Jamaica Observer
- January is Cervical Health Awareness Month KNIA KRLS Radio
- View Full Coverage on Google News
2 years 2 months ago
Cholera in Haiti: nearly 500 deaths
Port-au-Prince, Haiti
Nearly four months after its reappearance in Haiti, the number of cholera victims has risen to 496 dead, the Ministry of Public Health and Population (MSPP) reported Saturday.
The country has already registered 25,182 suspected cases and 21,407 hospitalized, 73 new, while 312 of the 496 deaths occurred in health institutions and 184 in the communities.
Port-au-Prince, Haiti
Nearly four months after its reappearance in Haiti, the number of cholera victims has risen to 496 dead, the Ministry of Public Health and Population (MSPP) reported Saturday.
The country has already registered 25,182 suspected cases and 21,407 hospitalized, 73 new, while 312 of the 496 deaths occurred in health institutions and 184 in the communities.
In a bulletin, the health authorities state that the average age of those infected is 19 years, and the positivity rate is 37.25%.
56.60% of the accumulated suspected cases are men, and the remaining are women. The most affected age group is 1 to 4 years old, with 374 confirmed cases out of more than 3,000 suspected cases.
The most affected department is the West, where Port-au-Prince is located and where more than one-third of the population lives, with 1,155 confirmed cases for 16,408 suspected cases.
The World Health Organization (WHO) warned last week that the world is suffering unprecedented cholera outbreaks in countries affected by climate disasters and other crises. As a result, vaccines to prevent this disease have become “extremely scarce.”
2 years 2 months ago
Health, World
What Public Health will do against malaria in San Juan
The Minister of Health and Social Assistance, Daniel Rivera, visited several places in this province, starting at the San Juan Provincial Directorate Regional VI, where he ordered to reinforce of the strategies and evaluate the malaria situation in this province since 70 percent of the confirmed cases at the national level are concentrated in the area.
During the meeting, the president of the Health Cabinet also evaluated the implementation of the “Malaria Elimination Strategy” carried out by the technical team of epidemiologists of the San Juan Provincial Health Directorate and presented by Dr. Rosa Alvino, focused on projecting and reinforcing strategies that can reduce the indicators of the disease.
“Today we are here to kick off a strategic program carried out by epidemiological team, since this province has the highest number of cases registered in the country; no one has died from the disease, but we have to focus on reducing cases,” the official said.
He suggested visiting the transmission centers two or three times a week to keep control of the situation and continue with the prevention strategies in the area, “it is very important to work on the operational part, taking into account the specific points of transmission, we have to go to the field where the active focus is,” he recommended.
Before the meeting, Dr. Rivera visited the facilities of the company Maguana Tropical, where he spoke with its production manager, Edwin Ordas, about the safety and hygiene measures that are being carried out to prevent malaria, cholera, and other diseases.
He also held a meeting with the director of the Centro Universitario Regional Oeste Curo- UASD, Carlos Manuel Sánchez, with whom he discussed health issues and analyzed the support to students of different careers in the prevention of viral diseases and other types of operations carried out by the Provincial Health Office.
He also went to the call of the bishop, Monsignor Tomas Concepción of the church Diocese of San Juan de la Maguana, along with the priest Pedro Pablo Mateo, to agree to expedite the process of requesting medicines; so that they arrive on time when requested by the episcopate.
“Those processes can be expedited through Habilitation and Accreditation; it is neither difficult nor impossible; besides, for us, the church should always be given priority,” concluded Dr. Rivera.
2 years 2 months ago
Health, Local
How telemedicine can aid the fight against cervical cancer
CERVICAL cancer is the second most frequent cancer affecting Jamaica women aged 15-44 as of 2021. This type of cancer affects the cervix which is a part of the female reproductive system and grows slowly over time. The good news is, yearly screening, early detection and vaccines are all ways in which cervical cancer can be controlled.
The cervix is the lowest part of the uterus and connects the uterus to the vagina. It is covered in tissues made up of cells that grow and change. Sometimes, these can become abnormal. Most cases of cervical cancer are caused by the HPV virus forming cancerous cells in the cervix.
Abnormalities of the cervix can be detected, destroyed and removed before it reaches the cancerous stage. If detected too late, they can spread or grow deeper causing great damage and discomfort. Symptoms of concern include vaginal bleeding between periods, pain during intercourse, pelvic pain and unusual discharge. These symptoms are also common to various ailments of the female reproductive system. Therefore, it is necessary that women over 18 do a yearly Pap smear test with their gynaecologist to ensure any abnormalities are detected.
With this type of cancer affecting such a large population of women, it is crucial that greater access to resources for prevention and early detection are made available to women across the island. Telemedicine platforms, such as MDLink, are one such resource that can aid in limiting the number of women affected by cervical cancer in Jamaica. The following are key ways telemedicine can aid in the fight against cervical cancer:
Early detection
Early detection leads to a decrease in death and disease of cervical cancer. If you believe you are experiencing issues aligned with early signs of cervical cancer or HPV, reaching out to a gynaecologist online may be a useful first step. MDLink can serve as your first step in assessing the symptoms you are experiencing in order to determine if you should be further tested for cervical cancer (through a Pap smear, HPV test or pelvic examination) or if it can be ruled out with another diagnosis. Additionally, your physicians can send over a prescription virtually to help ease your symptoms without you ever having to go in office. Taking advantage of the services MDLink has to offer may save you the time and money for an in-person gynaecologist visit.
Efficient follow-up
After a positive HPV screening or an abnormal Pap smear, you and your doctor can utilise telemedicine to take advantage of out-of-office care and advice. These results do not necessarily suggest that you have cancer and your gynaecologist can discuss with you what the results mean and what your next steps will be. Next steps may include surgery, self-examinations, medication and/or additional screenings. Telemedicine allows you to meet with your doctor via telephone, video call or audio call, all while in your office, home or car — wherever is most comfortable and convenient. It is an advantageous next step, particularly if your follow-up care is not emergent.
Increased access to specialist care
With a shortage of specialists concentrated in urban areas, telemedicine allows those who live in rural areas or outside of busy cities to also gain access to the same level of specialist care with a gynaecologist. Patients are able to know they are getting the best treatment with the most experienced doctors all without the inconvenience of travelling far for assessments and treatment.
Easy access to professional advice relating to vaccines and treatment
The HPV vaccine is one of the main preventative treatments that women aged 18 and older can take to prevent these cell changes and reduce the risk of cervical cancer. Telemedicine can be the starting point in speaking with your doctor about the safety, efficiency and side effects of taking this vaccine.
Ensuring that our women have reliable, convenient and safe access to modern health care is vital to a healthy nation. Cervical cancer affects our mothers, sisters, aunts, friends and family and telemedicine platforms such as MDLink seek to ensure that everyone, regardless of their age or social standing, has access to the highest standard of specialist care. Limiting the cases of cervical cancer will ensure long and healthy lives and telemedicine is just one tool which can be taken advantage of to support our women.
Dr Ché Bowen, a digital health entrepreneur and family physician, is the
CEO & founder of MDLink, a digital health company that provides telemedicine options. Check out the company's website at www.theMDLink.com. You can also contact him at drchebowen@themdlink.com.
2 years 2 months ago
What it means to access health care — Pt 1
HEALTH care is a state of complete physical, mental, and social well-being, not merely the absence of disease or infirmity. Access to adequate health care is a global problem in low, middle-income, and high-income countries.
What does it mean to access health care? Health care access is the ability to obtain health-care services such as prevention, diagnosis, treatment, and management of diseases, illnesses, disorders, and other health-impacting conditions. For health care to be accessible, it must be affordable, convenient, and of acceptable quality. The World Health Organization (WHO) has long believed that health care is a fundamental right. The best way to pursue this is universal health care. Reports in 2019 suggested that up to half the world's population did not have access to essential medical services. Further estimates indicate that medical costs put 100 million people into severe poverty every year.
Universal access to health care
The goal of the WHO is universal health care, in this scenario, there should be no "out-of-pocket costs" for those seeking care. The universal health-care programme of the WHO tracks "catastrophic health care spending" to identify persons with inadequate access to health care. This is defined as patients who spend more than 10 per cent of their household budget on medical services. The aim would be that this population should be less than 20 per cent of a country's population. In 2018, as part of the millennial developmental goals, it targeted increasing access to health care by one billion persons worldwide by the year 2023, primarily by increasing access to universal health care. In the first month of 2023, the goal has not been reached and, in fact, the increase has only been 160 to 200 million individuals. Given that health care provision requires economic resources, it is not surprising that countries with the lowest gross domestic product (GDP) per capita have the highest rates of inadequate access to health care.
There is a clear association between rising levels of GDP per capita and a greater proportion of the population that can access health care. This is a vexing problem in lower-income countries where access to health care is limited for many people because of the associated costs of seeking care. In many countries, there is limited access to third-party health care payers, and the regulatory environment that compels third-party payers to honour their agreements is weak. There is some good news among the bad, however. Although starting from a weak base, the most significant increases in access to care were seen on the African continent, where several countries experienced a more than 30 per cent increase in the population who did not require catastrophic health care spending. As the COVID-19 pandemic and worldwide inflation subside, we may see significant increases in health care access.
Role of the Government in facilitating access to health care
Access to health care starts at the country or government level. Health-care services can be provided through the Government entirely, such as when a government funds health care, builds hospitals and clinics, employs medical personnel, and is responsible for the health-care system in its entirety. A classic example may be Cuba.
Most countries, including Jamaica, have a mixture of public and private provision of health-care services, with government-provided or public health care accessible for the population at large and a private health-care market for those who wish to access it.
The degree to which the private market supplies health care varies quite significantly among nations. In the United Kingdom, the National Health Service (NHS) plays the leading role in health-care delivery, but there is access to private care, which is paid for directly or through commercial insurance. The Canadian system is one in which the Government funds most health care costs, but much of the care is delivered by private actors. The United States is a country where the private market plays a more significant role than many others. Most US health care is privately funded, except for government intervention for defined populations through the Centres for Medicare and Medicaid Services (CMS) and the Veterans Administration Hospital systems for veterans. Even when the Government underwrites care, it is primarily extended in private facilities.
Given that resources are finite, any country with a significant public aspect to health care will need to decide how much money can be spent each year. This must be done in conjunction with spending in other areas of similar or greater importance. For instance, the Government of Jamaica has to fund national security (including the police, customs, and immigration), the judiciary, the education system, national infrastructure, and health care. More money for health care means less money for these competing priorities. Given the rise in chronic diseases, the increasing use of technology in medicine, and the ageing of our population, the amount of money that needs to be spent increases over time. In an ideal world, these changes would be accompanied by a rise in the GDP and a rise in the percentage of the budget that can be directed toward health care. As a low-middle income country in 2019, Jamaica spent about 6.1 per cent of its budget on health care, with a per capita spending of only US$327 per person. Compare this with the United Kingdom, which in 2022 spent 11.9 per cent of its GDP on health care with a per capita spending of 3,840 pounds (US$4,696.26), or the United States, which spent 18.3 per cent of its GDP on health care in 2021 for a per capita spending of US$12,914.
The amount of money available to spend will dictate what services can be offered to the public. Primary care services such as vaccination, antenatal visits, outpatient management, and disease prevention are relatively inexpensive to provide and can be offered to a substantial proportion of the population at low cost. These measures also generally deliver significant improvements in public health and tend to be in the service mix of all countries. At the other extreme are services that are very expensive to provide, and which are utilised by a very small segment of the population. Some examples include bone marrow transplantation for childhood leukaemia, solid organ transplantation, and gene therapy for sickle cell disease. Given that resources are finite and limited, should we pay 200,000 US dollars for organ transplantation or vaccinate our school-age population? This is an extreme example, but the fact is that the Government must make trade-offs in deciding what services are to be provided and thus accessed by the population.
Dr Ernest Madu, MD, FACC and Dr Paul Edwards, MD, FACC are consultant cardiologists for the Heart Institute of the Caribbean (HIC) and HIC Heart Hospital. HIC is the regional centre of excellence for cardiovascular care in the English-speaking Caribbean and has pioneered a transformation in the way cardiovascular care is delivered in the region. HIC Heart Hospital is registered by the Ministry of Health and Wellness and is the only heart hospital in Jamaica. Send correspondence to info@caribbeanheart.com or call 876-906-2107
2 years 2 months ago
Flavoured cannabis marketing is criticised for targeting kids
NEW YORK, United States (AP) — When New York's first licensed recreational marijuana outlet opened last month, the chief of the state's Office of Cannabis Management, Chris Alexander, proudly hoisted a tin of watermelon-flavoured gummies above the crowd.
Outside the Manhattan shop, he displayed another purchase — a jar containing dried flowers of a cannabis strain called Banana Runtz, which some aficionados say has overtones of "fresh, fruity banana and sour candy".
Inside the store run by the non-profit Housing Works, shelves brimmed with vape cartridges suggesting flavours of pineapple, grapefruit and cereal milk, written in rainbow bubble letter print.
For decades, health advocates have chided the tobacco industry for marketing harmful nicotine products to children, resulting in more cities and states, like New York, outlawing flavoured tobacco products, including e-cigarettes.
Now as cannabis shops proliferate across the country, the same concerns are growing over the packaging and marketing of flavoured cannabis that critics say could entice children to partake of products labelled "mad mango", "loud lemon" and "peach dream".
"We should learn from the nicotine space, and I certainly would advocate that we should place similar concern on cannabis products in terms of their appealability to youth," said Katherine Keyes, a professor of epidemiology at Columbia University who has written extensively about the rise in marijuana use among young people.
"If you go through a cannabis dispensary right now," she said, "it's almost absurd how youth-oriented a lot of the packaging and the products are."
Keyes added that public health policymakers — and researchers like her — are trying to catch up with an industry and marketplace that is rapidly expanding and evolving.
New York, which legalised recreational marijuana in March 2021, forbids marketing and advertising that "is designed in any way to appeal to children or other minors".
But New York's state Office of Cannabis Management (OCM) has yet to officially adopt rules on labelling, packaging and advertising that could ban cartoons and neon colours, as well as prohibit depictions of food, candy, soda, drinks, cookies or cereal on packaging — all of which, the agency suggests, could attract people under 21.
"Consumers need to be aware — parents need to be aware — if they see products that look like other products that are commonly marketed to kids, that's an illicit market product," said Lyla Hunt, OCM's deputy director of public health and campaigns.
Hunt recently saw a cannabis product calling itself "Stony Patch Kids" that she said looked like the popular candy "Sour Patch Kids".
Similar products are being sold by the dozens of illegal pot dispensaries that operate out in the open and that officials worry are selling unsafe products. Once packaging and marketing standards are established, the illicit marketplace will likely not comply, experts say.
State officials hope that products bought at licensed dispensaries will help.
"We can regulate until we're blue in the face. But the truth is, it's a partnership between a compliant industry, strong regulations that are robust in their protections for youth and then with parents, too," Hunt said.
New York Governor Kathy Hochul announced Thursday the upcoming opening of the state's second legal dispensary, which will be located in Manhattan's West Village. The new venture — called "Smacked" — will open as a pop-up next week before opening a permanent location.
Under state law, a minor in possession of marijuana would face a civil penalty of not more than $50. Licensed cannabis retailers who sell to minors face fines and the loss of their licences, but no jail time.
Science has long established the addictive nature of nicotine and the health maladies associated with smoking tobacco, including cancer and emphysema.
Less settled are the health repercussions from vaping, particularly among children whose bodies and internal organs have yet to fully develop.
While smoking tobacco cigarettes has fallen among teens and young adults, the use of e-cigarettes and vapes has risen.
A handful of states — California, Massachusetts, New Jersey, New York, and Rhode Island — have bans on most flavoured tobacco products, including e-cigarettes and vapes. An increasing number of cities, including New York City, also have similar bans.
But those rules need to be broadened to include marijuana, said Linda Richter with the Partnership to End Addiction, who says the issue has yet to be widely addressed.
"There is more scrutiny on the tobacco industry, and very, very little in terms of rules, regulations, scrutiny, limitations when it comes to the cannabis industry," she said.
Because of the relative infancy of the legalised industry, she added, states have yet to coalesce rules on a single national standard. States often look to the federal government to set those standards, but marijuana remains illegal on the federal level.
"That's a real issue where you don't have the weight of the federal government in terms of standards of packaging and marketing," to set parameters to avoid appealing marketing to young people, Richter said.
Anti-smoking groups, including the Campaign for Tobacco-Free Kids, have long railed against the tobacco industry for its marketing, such as using cartoon characters to help market their products. In more recent years, they've campaigned against flavoured nicotine products, including those in vaping form.
But thus far, such groups have not put the marijuana industry in its cross-hairs.
A study released earlier this month documented the steep rise in poisonings among young children, especially toddlers, who accidentally ate marijuana-laced treats.
The uptick in cases coincides with the rise in the number of states allowing the use of marijuana for medicine or recreation. Medical use of cannabis is currently allowed in 37 US states, while 21 states allow recreational use.
"When you're talking about strawberry cheesecake, or mango, or cookies and cream flavours, it's very difficult to argue that those are for older adults," said Dr Pamela Ling, the director for the Centre for Tobacco Control Research and Education at the University of California in San Francisco.
"Folks who consider themselves to be more like cannabis aficionados," she said, "would say that smoking a flavoured cannabis product is like putting ketchup on your steak."
2 years 2 months ago
Another cholera death suspected in Santo Domingo East
Santo Domingo
This Friday, another person died in the Villa Liberación sector, in El Almirante, Santo Domingo East, presumably from cholera, but laboratory tests will be needed to confirm this.
This death occurs amid the concern generated in this sector by the spread of cholera, which according to community members, has left at least five dead.
Santo Domingo
This Friday, another person died in the Villa Liberación sector, in El Almirante, Santo Domingo East, presumably from cholera, but laboratory tests will be needed to confirm this.
This death occurs amid the concern generated in this sector by the spread of cholera, which according to community members, has left at least five dead.
At least six cases have been confirmed, and others are awaiting test results.
The Public Health authorities intervened in the sector to stop the disease, installing a mobile hospital in the Center for Diagnosis and Primary Attention of the Villa Liberation sector to treat suspected cases.
Among the actions they carry out is searching for suspected cases to provide immediate Attention. In addition, they have asked those with diarrheal symptoms not to waste time and seek assistance.
Since the first case of cholera was registered in the country, following the increase in cases in Haiti, the authorities have set up a cordon in La Zurza, Capotillo, and other sectors near the banks of the Isabela River, where the presence of the bacteria that causes cholera has been confirmed.
The Ministry of Public Health and the Santo Domingo Water and Sewage Corporation (Caasd), among other government institutions, are involved in the actions.
2 years 2 months ago
Health, Local
Medical News, Health News Latest, Medical News Today - Medical Dialogues |
FNB Hand and Micro Surgery: Check Out NBE Released Curriculum
The National Board of Examinations (NBE) has released the curriculum for FNB Hand and Micro Surgery.
I. PROGRAMME GOALS & OBJECTIVES
1. PROGRAMME GOAL
The National Board of Examinations (NBE) has released the curriculum for FNB Hand and Micro Surgery.
I. PROGRAMME GOALS & OBJECTIVES
1. PROGRAMME GOAL
The goal of the Hand Surgery and Microsurgery Fellowship of the Departments of Plastic Surgery and Orthopaedic Surgery and its affiliates is to prepare physicians for a career in Hand surgery either as clinical surgeons or academic surgeons. It is the goal of the program to recruit outstanding men and women who desire to become leaders in their community or academic program
It is the goal of the program to have residents/fellows understands the practice of Hand and Micro surgery and to provide ethical lessons through faculty example and discussion. It is our goal for the resident/fellow to be competent in the knowledge of the practice of Hand surgery, to carry out this practice in a professional and ethical manner, to develop skills for continuing and self-reflective education in the field of hand surgery, and to understand hand surgery in the context of the healthcare system in which they will practice.
The purpose is to help the Fellow develop an understanding of surgical and medical management of musculoskeletal problems of the entire upper extremity. The program provides a mix of basic hand surgery and complex hand surgery conditions.
The goal Hand and Upper Extremity Fellowship is to optimally prepare surgeons- in-training to render contemporary, compassionate and fiscally-responsible care for all pathologies afflicting the hand, wrist, while inspiring the fellow to give back to the specialty through engagement in scientific inquiry and practice as a life-long learner and teacher.
Training emphasizes traumatic and acquired conditions of the hand, wrist, forearm, elbow, arm, and shoulder including peripheral nerve disorders, microsurgical training in collaboration with Plastic Surgery, brachial plexus arthroscopy of the hand, wrist, joint replacement of the hand, wrist, and congenital hand surgery.
2. PROGRAMME OBJECTIVES
The fellowship combines clinical, teaching, and research opportunities for Plastic, Orthopaedic and General surgeons interested in furthering their knowledge of the upper extremity. Training emphasizes traumatic, congenital, and acquired conditions of the hand, wrist, forearm, and elbow.
Objectives include:
i. Development of clinical expertise in the diagnosis and management of disorders involving the upper extremity.
ii. Refinement of clinical skills so new problems can be addressed based on path physiologic and patient-oriented information, allowing an appropriate course of action to be initiated.
iii. Attainment of surgical expertise in traumatic, congenital, and acquired disorders of the upper extremity.
iv. Exposure to research investigations including clinical review and outcomes, and basic science research.
a. These objectives are attained through competency-based educational methods including instruction and formal research experience.
II. TEACHING AND TRAINING ACTIVITIES
The fundamental components of the teaching programme should include:
1. Case presentations & discussion- once a week
2. Seminar - Once a week
3. Journal club - Once a month
4. Faculty lecture teaching- once a week
5. Clinical Audit-Once a Month
6. A poster and have one oral presentation at least once during their training period in a recognized conference.
7. One publication in a national journal and one in an international journal
The rounds should include bedside sessions, file rounds & documentation of case history and examination, progress notes, round discussions, investigations and management plan) Aspects of training would include,
Theoretical: The theoretical knowledge would be imparted to the candidates through discussions, journal clubs, symposia and seminars. The students are exposed to recent advances through discussions in journal clubs.
Symposia: Trainees would be required to present a minimum of 20 topics based on the curriculum in a period of three years to the combined class of teachers and students. A free discussion would be encouraged in these symposia. The topics of the symposia would be given to the trainees with the dates for presentation.
Clinical: The trainee would be attached to a faculty member to be able to pick up methods of history taking, examination, prescription writing and management in rehabilitation practice.
Bedside: The trainee would work up cases, learn management of cases by discussion with faculty of the department.
Journal Clubs: This would be a once a month academic exercise. A list of suggested Journals is given towards the end of this document. The candidate would summarize and discuss the scientific article critically. A faculty member will suggest the article and moderate the discussion, with participation by other faculty members and resident doctors. The contributions made by the article in furtherance of the scientific knowledge and limitations, if any, will be highlighted.
Microsurgery Lab Course: All candidates must undergo one week microsurgery laboratory course either in the institution selected or where it is regularly conducted.
Research: The student would carry out the research project in accordance with NBE guidelines. He/ she would also be given exposure to partake in the research projects going on in the departments to learn their planning, methodology and execution so as to learn various aspects of research
III. SYLLABUS
THEORY
Basic Sciences
• Anatomy of the hand and upper limb
• Embryology of the Hand and Upper Limb
• Physiology of muscle, nerve and bone metabolism
• Principles of infection, microbiology
• Healing of wound, tendon, bone, nerve
• Anatomy and physiology of blood supply to limb including skin
• Imaging (MRI, Ultrasound, Plain radiographs, CT)
• Pathology of rheumatic, degenerative and neoplastic disorders
• Biomechanics of the hand and wrist
• Embryology of the Upper Extremity
• Basic Pathology of the Hand, Wrist, and Forearm: Bone and Joint
• Basic Pathology of the Hand, Wrist, and Forearm: Tendon and Ligament
• Basic Pathology of the Hand, Wrist, and Forearm: Nerve
• Basic Vascular Pathophysiology of the Hand, Wrist, and Forearm Principles of Hand Surgery
• Examination of nerves, tendons, vascular system, joints
• Injured hand - wound care, management of skeletal, vascular, tendon and nerve injuries
• Treatment of fractures and malunions of the hand
• Ligament ruptures and joint instabilities of the hand
• Arthroscopy of the hand and wrist
• Amputations in the hand and upper limb
• Burns of the hand
• Reconstructive surgery of mutilated hand
• Management of upper limb nerve injuries, including brachial plexus injuries
• Management of tetraplegia, stroke, brain injury and cerebral palsy
• Tendon transfers
• Congenital abnormalities of hand and upper limb
• Arthrosis of the hand and wrist
• The arthritic hand in rheumatoid arthritis and other inflammatory arthritides, e.g. LES and scleroderma
• Dupuytren’s contracture
• Overuse syndromes
• Nerve compression syndromes
• Infections of the hand
• Vascular disorders (inc ischaemia,HAVS)
• Tumours of the hand
• Psychiatric manifestations, secondary gainetc.
• Principles of Hand Therapy
• Complex regional pain syndrome
• Skin grafts
• Local, distant and free flaps
• Extravasation injuries
• Enhancing wounds including specialised dressings and vacuum therapy
• Spasticity
Applied sciences
• Anesthesia in Hand and Upper Extremity Surgery
• Radiographic Imaging of the Hand, Wrist, and Forearm
• Principles of Hand Therapy
• Entraarticular Fractures of the Phalanges
• Extraarticular Fractures of the Metacarpals
• Intraarticular Injuries of the Distal and Proximal Interphalangeal Joints
• Intraarticular Injuries of the Metacarpophalangeal and Carpometacarpal Joints
• Fractures and Joint Injuries of the Thumb
• Malunion and Other Posttraumatic Complications in the Hand
• Fractures and Joint Injuries of the Child's Hand
• Extraarticular Distal Radius Fractures
• Intraarticular Distal Radius Fractures
• Acute Injuries of the Distal Ulna
• Malunion of the Distal Radius and Ulna
• Distal Radioulnar Joint Instability
• Triangular Fibrocartilage Complex Injuries and Ulnar Impaction Syndrome
• Fractures of the Carpus: Scaphoid Fractures
• Nonunions of the Carpus
• Wrist Instability
• Ligament Injuries and Instability of the Carpus
• Dissociations of the Radius and Ulna: Surgical Anatomy and Biomechanics
• Principles of wrist Arthroscopy
• Arthroscopic Repair and Stabilizati
• Arthroscopic Debridement, Resections, and Capsular Shrinkage
• Ganglionectomy
• Flexor Tendon Injuries
• Flexor Tendon Grafting
• Early Active Motion after Flexor Tendon Repair
• Early Repair of Extensor Tendon Injuries
• Extensor Tendon Reconstruction after Chronic Injuries
• Rehabilitation after Extensor Tendon Injury and Repair
• Tendon Disorders: de Quervain's Disease, Trigger Finger, and Generalized Tenosynovitis
• Tennis Elbow Entrapment Neuropathies in the Upper Extreimity
• Principles and technique of of Tendon Transfers following nerve injuries
• Brachial Plexus Injury: Acute Diagnosis and Treatment
• Brachial Plexus: Neurotization and Pedicle Muscle Transfer
• Brachial Plexus: Free Composite Tissue Transfers
• Reconstruction of the Spastic Hand
• Burns of the Hand and Upper Extremity
• Frostbite
• Dupuytren's Contracture
• Fingertip and Nailbed Injuries
• Skin Grafts and Tissue Expanders
• Skin and Soft Tissue: Pedicled Flaps
• Free Tissue Transfers for Coverage
• Rheumatoid Arthritis in the Hand and Digits
• Rheumatoid Arthritis of the Wrist
• Crystalline Arthritis and Other Arthritides
• Osteoarthritis of the Hand and Digits: Distal and Proximal Interphalangeal Joints
• Osteoarthritis of the Hand and Digits: Metacarpophalangeal and Carpometacarpal Joints
• Osteoarthritis of the Hand and Digits: Thumb
• Principles of Limited Wrist Arthrodesis
• Scaphotrapeziotrapezoid and Scaphocapitate Fusions
• Four-Corner Fusion
• Radiocarpal and Total Wrist Arthrodesis
• Proximal Row Carpectomy
• Wrist Arthroplasty
• Denervation of the Wrist
• Congenital Disorders: Classification and Diagnosis
• Congenital Disorders: Syndactyly
• Congenital Disorders: Polydactyly
• Congenital Disorders: Hypoplastic Thumb
• Congenital Disorders: Radial and Ulnar Club Hand
• Congenital Disorders: Cleft Hand
• Camptodactyly and Clinodactyly
• Delta Phalanx and Madelung's Deformity
• Macrodactyly, Constriction Band Syndrome, Synostosis
• Replantation
• Vascular Injuries: Acute Occlusive Conditions
• Compartment Syndromes and Ischemic Contracture
• Vascular Disorders: Arteriovenous Malformations
• Raynaud's Syndrome
• Thumb Reconstruction
• Finger Reconstruction and Ray Resection
• Wrist and Mid-Hand Reconstruction
• Tumors: General Principles
• Soft Tissue Tumors of the Hand: Malignant
• Primary Bone Tumors
• Metastatic Lesions
• Hand Infections
• Open-Wound, Injection, and Chemical Injuries
• Practical Guide for Complex Regional Pain Syndrome in the Acute Stage and Late Stage
• Pediatric Brachial Plexus Palsy
• Hand, Wrist, and Forearm Fractures in Children
• Rehabilitation
• Recent advances in hand and microsurgery
PRACTICAL
List of procedures follows a description with the operations to be performed independently by the trainee or, for operations of a higher degree of difficulty, as a participant. Microvascular experience is essential.
Surgical procedures can be listed according to the anatomical structures involved:
Skin and subcutaneous tissue
• Free skin graft
• Pedicled localflaps
• Regional and\or island flaps
• Free flap with microvascular anastomosis
• Treatment of retracting scars of the hand and wrist
• Application of vacuumtherapy
• Dupuytren’ s including PNF, collagenase, limited and radical surgery
• Extravasation
• Infection
Tendons
• Flexor tendon repair
• Flexor tendon graft
• Flexor pulley reconstruction
• Flexor tendon tenolysis
• Trigger finger release
• Extensor tendon repair
• Extensor tendon graft
• Extensor tendon tenolysis
• Tendon sheath synovialectomy
• Tendon reconstruction in rheumatoid arthritis
• Tendon transfers (injury, paralysis, spastic conditions)
• Free muscular flap with microvascular anastomosis
• Flexor sheath infection
Bone and Joints
• Closed reduction and fixation of fractures and dislocations
• Open reduction and fixation of fractures and dislocations
• Corrective osteotomies
• Treatment of non-union
• Bone resections
• Bone grafts and substitutes
• Free bone transfers with microvascular anastomosis
• Finger joint ligament or palmar plate repair\reconstruction
• Wrist ligament repair\reconstruction
• Arthrolysis 11. Digital\wrist arthroplasty (incl. allo-arthroplasty)
• Wrist partial and total fusion, PRC
• Hand Arthrodesis
• Denervation
• Synovectomy
• Arthroscopy
• DRUJ reconstruction
• Fractures in children
Nerves
• Microsurgical repair of nervelesions
• Nerve grafting and neurotisation andconduits
• Neurolysis
• Neuroma
Vascular
• Tumours and malformations
• Ischaemia (inc Kienbock’ s, Raynauld’ s)
• Replantation
• Revascularisation
Other
• Congenital disorders
• Children’ s disorders
• 5. Oncology- biopsy (transcutaneous, open); excision,reconstruction
• Brachial plexus repair\reconstruction
• Neuromas
• Nerve tumours
• Treatment of nerve compressionsyndromes
Blood vessels
• Microsurgical arterial anastomosis
• Microsurgical venous anastomosis
• Vein graft
• Adventitiectomy
List of procedures should also include operations for the treatment of complex trauma of the hand, special diseases, malformations:
Amputations
• Hand level
• Carpal or forearm\upper limb level
Replantation in limbamputations
• Digital or metacarpal level
• Carpal or forearm\upper limb level
• Lower limb
Treatment of thermal burn, chemical injury, electrical trauma
Mangled hand treatment
Fasciotomy
• Acute
• Chronic
Infections of the Hand
• Treatment of wound infection incl. tendonsheath
• Treatment of paronychial or pulpinfection
• Treatment of osteomyelitis or septic arthritis
• Necrotising fasciitis
Tumours
• Resection of skin and soft tissue tumour
• Resection of bonetumour
• Resection of tumour-likelesion
Contracture
• Dupuytren’ s
• Volkmann’ s
• Stiffness
• Burns
Treatment of congenital malformations of the hand
RESEARCH
The Hand Surgeon should undertake some research during his/her training, At the very least, a thorough understanding of the basics of research is essential
• Formulating a hypothesis
• Designing an appropriate methodology to test that hypothesis
• Using appropriate statistics to report the research
• Deducing appropriate conclusions form the data
• Understanding the limitations of a study
• Epidemiological principles
Biostatistics, Research Methodology and Clinical Epidemiology Ethics Medico legal aspects relevant to the discipline
Health Policy issues as may be applicable to the discipline
In addition, the Hand Fellow will attend one national Hand Surgery meeting and is encouraged to become a member of the National body of Hand Surgery.
Skills
Intellectual Skills
Education: A Hand Surgeon must be able to critically assess a research article or podium presentation, to understand the strengths and weaknesses of the material and to apply it to his own practice.
Continuing Medical Education: Education is a life-long process; the Hand Surgeon should take personal responsibility to use all resources to improve and update his knowledge and practice.
Personal Skills
Team working: Hand Surgeons work with theatre teams, therapists, nurses, junior doctors and many others who are involved in the care of patients. The Hand Surgeon will often be the leader of the team and should develop the necessary qualities of leadership.
Delegation: Many problems in Hand Surgery can be shared with others. The Hand Surgeon should develop skills of delegation so that patient care can be safely delegated to the appropriate practitioner to help provide an efficient, safe and cost- effective service.
Time Management and Stress Management: Surgery is stressful. It requires long hours with many competing demands on time and skill. Some decisions are uncertain; some procedures are very complex with potentially serious complications and uncertain outcome. The Hand Surgeon must learn to manage time and cope with stress.
Referral: The Hand Surgeon must appreciate the responsibility of asking for advice or referring to another practitioner when a case is beyond his expertise or comfort.
Other Skills
Consent: Informed consent is important in developingt he confidence of a patient by engaging them in the choice of treatmen and avoiding medico-legal issues with unexpected outcomes.
Documentation: Clear contemporaneous documentation is important for many reasons: to allow proper handover, for example post-operative instructions; to record the basis of clinical decisions; for medico-legal protection; to collect data for research and audit.
Service Management: A Hand Surgeon must be able to prioritise and also develop the skills to manage their service with the skills, resources and personnel available
IV. COMPETENCIES
1. Patient Care
a) Demonstrate appropriate evaluation and treatment of patients with hand surgery problems in the emergency room and as part of the inpatient consultation service, including application of physical examination tests specific to the diagnosis.
b) Be able to examine the injured hand with a high level of sophistication and detail to determine any bony or ligamentous injury, flexor or extensor tendon injury, nerve injury, arterial injury, and infections of the upper extremity.
c) Be able to perform a detailed clinical examination of the forearm and wrist.
d) Be able to order appropriate diagnostic tests and imaging studies to assist with diagnosis and accurate assessment of the level/severity of the injury.
e) Be able to initiate and interpret a logical course of investigations for patients complaining of chronic wrist pain, including bone scan, arthrogram, CT scan and MRI scan of the wrist.
f) Be able to interpret x-rays of fractures of the wrist and hand to determine the need for closed reduction or admission for open reduction and internal fixation.
g) In consultation with the appropriate hand surgery attending, provide treatment for the patient as appropriate for level of training as a hand surgery fellow.
h) Be able to treat both simple and complex infections of the hand, wrist and forearm (e.g. flexor tenosynovitis, large or complex abscess, deep space infections of the hand, complicated cellulitis requiring inpatient therapy, necrotizing fasciitis, etc.).
i) Be able to reduce and apply appropriate cast immobilization for displaced or angulated fractures of the metacarpals, phalanges and distal radius.
j) Be able to repair nail bed injuries or apply split thickness or full thickness skin grafts for fingertip injuries.
k) Be able to perform steroid injections of the A1 pulley of the flexor tendon sheath for trigger fingers, first dorsal extensor compartment for deQuervain's tenosynovitis, lateral/medial epicondyle for epicondylitis, and carpal tunnel for carpal tunnel syndrome.
l) Demonstrate a thorough understanding of the operative anatomy and be able to perform at least the following procedures:
• Open reduction and internal fixation of metacarpal and phalangeal fractures using K- wires, interosseous wires, interfragmentary and/or lag screws, and screws and plates.
• Repair/reconstruction of ligament injuries in the hand (e.g. repair of thumb MP joint ulnar collateral ligament rupture).
• Carpal tunnel release, radial tunnel release, cubital tunnel release, and radial tunnel release.
• Open reduction and internal fixation of scaphoid fractures.
• Russe bone graft, distal radius bone graft, iliac crest bone graft, and vascularized bone graft for scaphoid nonunions.
• Release of Dupuytren's contracture, including needle aponeurotomy.
• Arthrodesis of interphalangeal joints.
• Understand the operative approach to the digits (Bruner approach).
• Dorsal and volar approaches to the wrist joint, including open reduction/internal fixation vs. closed reduction/percutaneous K-wire fixation of distal radius fractures.
• Treatment of ulnar shaft fractures.
• Wrist arthroscopy.
• Limited intercarpal fusions (e.g. STT fusion, four-corner fusion).
• Proximal row carpectomy.
• Complete wrist fusion.
• Syndactyly release and treatment of other common congenital hand differences.
• Lateral/medial epicondylectomy for epicondylitis.
• Tendon transfers.
• Radius and ulna shortening osteotomies.
• Distal ulna resection procedures (e.g. Darrach procedure, Feldon wafer procedure, Bower's hemiresection).
• Trapezium excisional arthroplasty for metacarpal-trapezial arthritis
• Extensor tendon repairs.
• Flexor tendon repairs, including "no man's land" repairs for zone II flexor tendon injuries.
• Tenolysis, secondary tendon reconstruction, flexor tendon sheath pulley reconstruction
• Extensor and flexor tendon grafting.
• Joint arthroplasties of the MP and PIP joints.
• Neurolysis.
• Excision of upper extremity tumors.
• Excision of common hand masses (giant cell tumor, ganglion cysts, mucous cysts, volar retinacular cysts, neuromas, schwannomas, etc.)
2. Be able to apply an external fixator for reduction of distal radius fractures.
3. Demonstrate microsurgical skills under the operating microscope and be able to perform microsurgical procedures such as arterial anastomoses, group fascicular nerve repair, nerve grafting and free tissue transfers.
4. Medical Knowledge
a) Develop an advanced understanding of the anatomy of the forearm, wrist and hand, including the bones, ligaments, tendons, nerves and arteries.
b) Demonstrate a thorough understanding of the treatment of fractures of the hand and wrist, fingertip injuries, tendon injuries, nerve injuries.
c) Demonstrate ability to diagnose and treat nerve compression syndromes, including carpal tunnel syndrome, cubital tunnel syndrome and radial tunnel syndrome.
d) Understand the indications and contraindications for replantation in the upper extremity.
e) Be able to perform reconstructive hand surgery, including treatment for congenital hand anomalies, tendon transfers and Dupuytren's contracture.
f) Focused reading of other appropriate textbooks and journals of hand surgery, Incorporate online sources of information available on the internet to augment the knowledge base and to facilitate acquiring specific information for specific questions or problems that arise.
g) Demonstrate a detailed understanding of the use of splints for fracture immobilization and tendon rehabilitation.
h) Prepare and present at least three 45-minute presentations on three different hand surgery topics at the weekly hand service conference during the rotation (over a twelve-month period).
i) Prepare and present a monthly report for the hand surgery Morbidity and Mortality conference, including a detailed presentation of "Cases of the Month".
j) Attend and participate at the weekly hand service conference during the rotation.
k) Attend the orthopaedic residents' journal club that focuses on hand surgery, hosted 2-3 times per year by Drs. Azari, Meals and Benhaim.
l) Attend and participate at the biannual lecture series on hand surgery (24 lectures total), presented at the weekly orthopaedic surgery basic science course on Wednesday mornings.
m) Attend the monthly hand surgery journal club, hosted by Dr. Meals at his home.
5. Practice-Based Learning and Improvement
a) Frequently use, in a focused fashion, the available printed textbooks, online textbooks, and Medline sources for application to specific patients. The goal is to demonstrate the ability to locate and interpret scientific studies and known medical knowledge into an appropriate knowledge base that will be of direct benefit to patients.
b) Frequently present and discuss patients with the attending hand surgeons after initial evaluation and review of available diagnostic tests to confirm the appropriate treatment plan. The hand fellow will be expected to formulate a plan of treatment, which will then be reviewed in detail and either confirmed or altered as necessary to achieve optimal patient outcome.
c) Use appropriate sources (e.g. textbook, selected articles from the literature, etc.) to obtain more detailed information about a specific patient or diagnosis, based on his/her experiences on the hand surgery service and any specific questions that arise as part of that experience/exposure.
d) Play an active role in the teaching of senior orthopaedic surgery residents, junior plastic surgery residents, junior orthopaedic residents, sports medicine fellows, senior medical students (sub-interns) and junior medical students on the service.
e) Demonstrate expertise in use of available information technology and hospital information systems to manage patient data (e.g. lab tests, imaging tests, etc.) and access online information that will be of direct benefit to his/her own education.
f) Integrate feedback from faculty to ensure that the hand fellow is able to analyze his/her own practice experience, with the goal of improving future patient care. Feedback is provided systematically at the weekly hand service conference, which includes a morbidity and mortality format to identify areas of potential improvement for all members of the hand surgery service.
g) Undergo formal evaluation at least twice per year, including review of progress and suggestions for improvement).
6. Interpersonal and Communication Skills
a) Demonstrate ability to communicate effectively with all members of the hand service, including medical students, junior residents, senior residents, sports medicine fellows, and hand surgery attending staff.
b) Demonstrate ability to communicate effectively and work well with all members of the hospital staff, including nurses, nursing assistants, radiology staff, social workers, discharge planners, physical therapists, hand therapists, operating room/surgery center staff, inpatient/outpatient support staff, etc.
c) Demonstrate the ability to interact effectively, professionally, and empathetically with patients and family members.
d) Demonstrate the ability to provide appropriate and detailed information to patients and family members, when appropriate.
e) Demonstrate the ability to develop an appropriate relationship with a patient that fosters communication, respect, and ethics of the highest degree.
f) Demonstrate the ability to recognize important cultural and generational differences that may affect patient care, and to apply appropriate changes in approach to these patients that respect these important differences (e.g. amputation of a digit in Asian cultures has important cultural implications that need to be addressed).
g) Demonstrate effective listening and communication skills with patients, which may include both verbal and non-verbal skills.
h) Demonstrate ability to understand and respond appropriately to patient inquiries.
7. Professionalism
a) Demonstrate a strict adherence to medical/ethical principles.
b) Demonstrate a keen sensitivity to the differences and challenges that a diverse patient population may present.
c) Treat all patients with respect, empathy, and with compassionate care. All patient inquiries and requests will be considered seriously, professionally, and in a timely manner.
d) Recognize the important social, economic, emotional, and work-related implications that a hand problem or injury may represent for the patient.
e) Provide patients with excellent care in all aspects.
f) Maintain patient confidentiality, including strict adherence to HIPPA guidelines.
g) Obtain informed consent from patients in accordance with established guidelines that ensure full patient comprehension after a detailed discussion of all pertinent issues relating to patient care/surgery. This includes the opportunity for the patient to ask and have answered questions relating to any proposed procedures.
h) Demonstrate the ability to accommodate and adapt to differences in patients' culture, age, gender and disabilities.
8. Systems-Based Practice
a) Develop an awareness of how the care that they provide to patients can affect other caregivers and in general.
b) Demonstrate an ability to effectively utilize hospital resources in a way that directly benefits patient care.
c) Develop a more in-depth understanding of the different types of medical practice available in the context of hand surgery..
d) Develop a more detailed understanding of the differences in different payor types, such as worker's compensation, managed care, HMO, PPO, Medicare, MediCal, and student health insurance plans.
e) Develop a mature understanding of the necessity to provide efficient and cost- effective health care in the context of appropriate use of limited medical resources, yet without sacrificing quality of care.
f) Act as a patient advocate and assist patients in obtaining the necessary care, including coordination of post-discharge care if necessary (e.g. home health care, postoperative hand therapy, placement into appropriate rehabilitation facility, etc.).
V. LOG BOOK
A candidate shall maintain a log book of operations (assisted / performed) during the training period, certified by the concerned post graduate teacher / Head of the department / senior consultant.
This log book shall be made available to the board of examiners for their perusal at the time of the final examination.
The log book should show evidence that the before mentioned subjects were covered (with dates and the name of teacher(s) The candidate will maintain the record of all academic activities undertaken by him/her in log book .
1. Personal profile of the candidate
2. Educational qualification/Professional data
3. Record of case histories
4. Procedures learnt
5. Record of case Demonstration/Presentations
6. Every candidate, at the time of practical examination, will be required to produce performance record (log book) containing details of the work done by him/her during the entire period of training as per requirements of the log book. It should be duly certified by the supervisor as work done by the candidate and countersigned by the administrative Head of the Institution.
7. In the absence of production of log book, the result will not be declared.
VI. RECOMMENDED TEXT BOOKS AND JOURNALS
TEXT BOOKS
• Green's Operative Hand Surgery: 2-Volume Set, 6e 6th Edition by Scott W. Wolfe MD (Author), William C. Pederson MD (Author), Robert N. Hotchkiss MD (Author), Scott H. Kozin MD (Author)
• Lister’s The Hand :Diagnosis and Indications
• ASSH Manual of Hand Surgery By Warren C. Hammert, Martin I. Boyer, David J. Bozentka, Ryan Patrick Calfee
• Microsurgery Practice Manual by Robert.D.Acland and Raja S Sabapathy
• Operative Microsurgery by J.Brian Boyd and Neil F Jones
• Principles of Hand Surgery and Therapy Thomas E. Trumble, Ghazi M. Rayan, Mark E. Baratz
JOURNALS
• Journal of Hand Surgery, European Volume
• Journal of Hand Surgery (American)
• Journal of Hand Surgery (Asia Pacific)
• Hand Clinics
• Journal of Bone and Joint Surgery (American and British volumes)
• Techniques in Hand and Upper Extremity Surgery
• Plastic and Reconstructive Surgery
• Journal of Plastic Reconstructive and Aesthetic Surgery
• Indian Journal of Plastic Surgery
• Indian Journal of Orthopaedics
• Internet sources Pubmed Medscape Web of Science
2 years 2 months ago
State News,News,Health news,Delhi,NBE News,Medical Education,Medical Colleges News,Medical Courses News,Medical Universities News,Medical Admission News,Latest Medical Education News,Medical Courses,Medical Courses Curriculum
Medical News, Health News Latest, Medical News Today - Medical Dialogues |
CDSCO Drug Alert: 70 drug samples including GSK Betnovate C cream, Cipla's Junior Lanzol mentioned in the list
New Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 70 medicine batches for failing to qualify for a random drug sample test for the month of December– 2022.
These drug samples include Glimepiride Tablets I.P. 1mg manufactured by T & G Medicare, Levocetirizine Dihydrochloride Syrup manufactured by Apple Formulations, Atenolol & Amlodipine Tablets I.P. 50mg/5mg manufactured by Zee Laboratories, Paracetamol Tablets I.P. 500 mg manufactured by Orissa Drugs & Chemicals, Telmistad – 40 (Telmisartan Tablets IP 40 mg) manufactured by Statmed Private Limited and others.
In addition to this, the name of Betamethasone and Clioquinol Cream (BETNOVATE-C SKIN CREAM) manufactured by GlaxoSmithKline Pharmaceuticals is also on the list of samples declared as Not of Standard Quality due to failure of Identification test and Assay of Betamethasone Valerate calculated as Betamethasone and Clioquinol. Having said that, the alert also carries a remark noting that on response to the aforementioned alert, pharmaceutical giant GlaxoSmithKline Pharmaceuticals has informed the CDSCO office about the availability of spurious/counterfeit versions of the specified batch of medication. "Investigation is under process," the CDSCO added to its note.
Furthermore, the list includes Junior Lanzol 15 mg (Lansoprazole Orally Disintegrating Tablets 15 mg) manufactured by Cipla and Sodium Valproate Tablets I.P. 200 mg manufactured by Bharat Parenterals.
The list came after analysis and test were conducted by the CDSCO, Drugs Control Departments on 1375 samples. Out of this, 1305 samples were found of standard quality while 70 of them were declared as Not of Standard Quality (NSQ).
A few of the reasons why the drug samples tested failed were the failure of the assay, failure of the dissolution test, failure of the disintegration test, failure of pH and identification test, failure of sterility test, failure of specific assay of drug test and others.
The samples collected were tested in six laboratories RDTL Guwahati, CDL Kolkata, CDTL Chennai, CDTL Mumbai, CDTL Hyderabad, RDTL Chandigarh.
List of Drugs, Medical Devices and Cosmetics declared as Not of Standard Quality/Spurious/Adulterated/Misbranded for the Month of December– 2022
Total number of samples tested
1375
Total number of samples declared as of Standard Quality
1305
Total number of samples declared as Not of Standard Quality
70
Total number of samples declared as Spurious
-
Total number of samples declared as Misbranded
-
S.No
Name of Drugs/medical device/cosmetics
Batch No./Date of Manufacture/Date of
Expiry/Manufactured By
Reason for failure
Drawn By
From
1.
OFLOWIND-OZ
(Ofloxacin & Ornidazole Tablets IP)
B. No.: G-T388
Mfg dt: 07/2021
Exp dt: 06/2023
Mfd by: M/s. Globin Pharmaceuticals Pvt. Ltd., Puhana Chowk, Dehradun Road, Roorkee, Dist. Haridwar Uttarakhand - 247667.
Dissolution “(Ofloxacin and Ornidazole)”
Drug Control Department Bihar
RDTL
Guwahati
2.
VOVEZAL-3
(Diclofenac Sodium Injection I.P.)
B. No.: GI-049
Mfg dt: 04/2021
Exp dt: 03/2023
Mfd by: M/s. Globin Pharmaceuticals Pvt. Ltd. Puhana Chowk, Dehradun Rd, Roorkee, Uttarakhand.
pH and Assay Content of Diclofenac Sodium
Drug Control Department Assam
RDTL
Guwahati
3.
Glimepiride Tablets
I.P. 1mg
B. No.: TGT12213097
Mfg dt: 12/2021
Exp dt: 11/2023
Mfd by: M/s. T & G Medicare, Village Kunjahal PO Baddi, Distt. Solan, Himachal Pradesh.
Dissolution
Drug Control Department Nagaland
RDTL
Guwahati
4.
KOOCAL-500
Tablets (Calcium with
Vitamin D Tablets IP)
B. No.: TG21-2346
Mfg dt: 09/2021
Exp dt: 02/2023
Mfd by: M/s. Athens Life Sciences Mauza Rampur Jattan, Nahan Road, Kala Amb, Distt. Sirmour Himachal Pradesh-173030
Identification and Assay of “Vitamin D3”
Drug Control Department Mizoram
RDTL
Guwahati
5.
Calcium with Vitamin D Tablets IP KOOCAL-500
B. No.: TG21-2539
Mfg dt: 10/2021
Exp dt: 03/2023
Mfd by: M/s. Athens Life Sciences, Mauza Rampur Jattan, Nahan Road, Kala Amb, Distt. Sirmour, Himachal Pradesh.- 173030.
“Identification and Assay/Content of Vitamin D3”
Drug Control Department Mizoram
RDTL
Guwahati
6.
Levocetirizine Dihydrochloride Syrup
B. No.: LZR-2204
Mfg dt: 01/2022
Exp dt: 12/2023
Mfd by: M/s. Apple Formulations Pvt. Ltd. Plot No. 208, Kishanpur, Roorkee-247667 Uttarakhand.
pH
Drug Control Department Bihar
RDTL
Guwahati
7.
Calcium and Vitamin D3 Tablets IP
(CALBICIN-D
FORTE Tablets)
B. No.: TGT12213182
Mfg dt: 12/2021
Exp dt: 06/2023
Mfd by: M/s. T & G Medicare, Village Kunjahal, PO Baddi, Distt. Solan, Himachal Pradesh.
Identification as well as Assay of “Vitamin D3”
Drug Control Department Nagaland
RDTL
Guwahati
8.
Atenolol & Amlodipine Tablets
I.P. 50mg/5mg
B. No.: Z22-013
Mfg dt: 01/2022
Exp dt: 12/2023
Mfd by: M/s. Zee Laboratories Ltd. Behind 47, Industrial Area, Paonta Sahib- 173025, Himachal Pradesh.
Dissolution (Amlodipine) and Assay/Content of Amlodipine
Drug Control Department Bihar
RDTL
Guwahati
9.
KOOCAL-500
Tablets (Calcium with
Vitamin D Tablets IP)
B. No.: TG21-2565
Mfg dt: 10/2021
Exp dt: 03/2023
Mfd by: M/s. Athens Life Sciences, Mauza Rampur Jattan, Nahan Road, Kala Amb, Distt. Sirmour, Himachal Pradesh – 173 030
Assay of “Vitamin D3”
Drug Control Department Mizoram
RDTL
Guwahati
10.
Lomolok (Loperamide Hydrochloride Tablets I.P.)
B. No.: T8842
Mfg dt: 07/2021
Exp dt: 06/2024
Mfd by: M/s. Quest Laboratories Pvt. Ltd., Plot No.-45, Sector-III, Indl. Area, Pithampur, Distt. Dhar-454775, Madhya Pradesh.
Assay
Drug Control Department Assam
RDTL
Guwahati
11.
CIPROFLOXACIN 250 (CIPROFLOXACIN HYDROCHLORIDE TABLETS I.P.
250 mg)
B. No.: 0600822
Mfg dt: 05/2022
Exp dt: 04/2025
Mfd by: M/s. KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LIMITED, Plot No. 14, II Phase, Peenya, Bengaluru – 560 058.
Dissolution
Drug Control Department Jharkhand
RDTL
Guwahati
12.
Omirid-10 (Omeprazole Capsules IP)
B. No.: OMI-2101
Mfg dt: APR.2021
Exp dt: MAR.2023
Mfd by: M/s. RIDLEY LIFE SCIENCE PVT. LTD., D-1651, DSIDC Indl. Complex, Narela, Delhi -110 040.
Dissolution
Drug Control Department Meghalaya
RDTL
Guwahati
13.
Rabeprazole Gastro Resistant Tablets IP 20 mg
B. No.: RRZT-016
Mfg dt: 12/2021
Exp dt: 11/2023
Mfd by: M/s. Revat Laboratories Pvt. Ltd. 12-321, Opp. I.D.A. Kurnool Road, Pernamitta, Ongole- 523002, Andhra Pradesh.
Dissolution (Buffer stage), Assay of Rabeprazole Sodium and Description
Drug Control Department Bihar
RDTL
Guwahati
14.
Iron & Folic Acid Syrup IP, 50 ml
B. No.: AHL21034
Mfg dt: 05/2021
Exp dt: 04/2023
Mfd by: M/s. ALVES HEALTHCARE PRIVATE LIMITED, Nangal Uparla, Swarghat Road, Nalagarh, Dist. Solan- 174 101, Himachal Pradesh, INDIA
‘pH’ and ‘Identification & Assay of Folic Acid’
Drug Control Department Jharkhand
RDTL
Guwahati
15.
Calcium with Vitamin D Tablets IP KOOCAL-500
B. No.: TG21-2564
Mfg dt: 10/2021
Exp dt: 03/2023
Mfd by: M/s. Athens Life Sciences Mauza Rampur Jattan, Nahan Road, Kala Amb, Distt. Sirmour, Himachal Pradesh – 173 030
“Identification and Assay of Vitamin D3”
Drug Control Department Mizoram
RDTL
Guwahati
16.
Iron & Folic Acid Syrup IP, 50 ml.
B. No.: AHL21015
Mfg dt: 05/2021
Exp dt: 04/2023
Mfd by: M/s. Alves Healthcare Private Limited, Nangal Uparla,a, Swarghat Road, Nalagarh, Dist. Solan- 174 101 Himachal Pradesh, India.
“pH”
and Identification & Assay of “Folic
Acid”
Drug Control Department Jharkhand
RDTL
Guwahati
17.
Levocetirizine Dihydrochloride Syrup
B. No.: LZR-2208
Mfg dt: 01/2022
Exp dt: 12/2023
Mfd by: M/s. Apple Formulations Pvt. Ltd. Plot No. 204, Kishanpur, Roorkee-247667 (U.K.).
‘pH’
Drug Control Department Bihar
RDTL
Guwahati
18.
Iron & Folic Acid Syrup IP (50 ml)
B. No.: AHL21012
Mfg dt: 05/2021
Exp dt: 04/2023
Mfd by: M/s. ALVES HEALTHCARE PRIVATE LIMITED, Nangal Uparla, Swarghat Road, Nalagarh, Distt. Solan- 174 101 Himachal Pradesh, INDIA.
‘pH’,
Identification & Assay of ‘Folic Acid’
Drug Control Department Jharkhand
RDTL
Guwahati
19.
GALPARA SUSPENSION (PARACETAMOL PAEDIATRIC ORAL SUSPENSION IP),
60m
B. No.: LGL-22157
Mfg dt: 03/2022
Exp dt: 02/2024
Mfd by: M/s. Prochem Pharmaceuticals Pvt. Ltd., 140-141, Makkanpur Bhagwanpur, Roorkee, Dist Haridwar-247661 Uttarakhand, India.
Assay of Paracetamol
Drug Control Department Meghalaya
RDTL
Guwahati
20.
GALPARA SUSPENSION
(Paracetamol Paediatric Oral Suspension I.P.)
B. No.: LGL-22157
Mfg dt: 03/2022
Exp dt: 02/2024
Mfd by: M/s. Prochem Pharmaceuticals Pvt. Ltd., 140-141, Makkanpur Bhagwanpur, Roorkee, Dist Haridwar-247661 Uttarakhand India.
Assay of Paracetamol
Drug Control Department Meghalaya
RDTL
Guwahati
21.
.
Levocetirizine Dihydrochloride Syrup, 30ml
B. No.: LZR-2204
Mfg dt: 01/2022
Exp dt: 12/2023
Mfd by: M/s. Apple Formulations Pvt. Ltd. Plot No. 208, Kishanpur, Roorkee-247667 Uttarakhand.
pH
Drug Control Department Bihar
RDTL
Guwahati
22.
Cifazime-AZ (Cefixime & Azithromycin Tablets)
B. No.: CZT-2101
Mfg dt: 02/2021
Exp dt: 01/2023
Mfd by: M/s. Fantasy Drugs Private Limited C-66 to 69, Industrial Area, Hajipur-844101, Bihar (India).
Identification of Azithromycin & Assay of Cefixime & Azithromycin
Drug Control Department Bihar
RDTL
Guwahati
23.
DSP (Diclofenac Potassium Serratiopeptidase & Paracetamol Tablets)
B. No.: LSAT-016
Mfg dt: 06/2021
Exp dt: 05/2023
Mfd by: M/s. LABORATE PHARMACEUTICALS INDIA LTD, (Unit-II) #31, Rajban Road, Nariwala Paonta Sahib, Himachal Pradesh
Description
Drug Control Department Jharkhand
RDTL
Guwahati
24.
Co-trimoxazole Tablets IP SS
B. No.: CM-122
Mfg dt: 05/2022
Exp dt: 04/2024
Mfd by: M/s. High Tech Pharma, 49, Khandelwal Compound, Plada, Indore Madhya Pradesh.
Disintegration
Drug Control Department Jharkhand
RDTL
Guwahati
25.
Moxiion-CV Dry Syrup (Amoxycillin & Potassium Clavulanate Oral Suspension), 3.3gm/30ml. with
water
B. No.: WJD-092C
Mfg dt: 08/2021
Exp dt: 01/2023
Mfd by: M/s. WELCURE REMEDIES Nahan Road, Vill Moginand, Distt. Sirmour - 173030 Himachal Pradesh.
Assay/ Content’ of
Clavulanic Acid
Drug Control Department Jharkhand
RDTL
Guwahati
26.
Amikacin Injection IP
B. No.: 21 AM02
Mfg dt: 03/2021
Exp dt: 02/2023
Mfd by: M/s. Sai Parenterals Pvt. Ltd., D4, Phase V, IDA, Jeedimetla, Hyderabad – 500055.
Description & Particulate Matter
Drug Control Department Andhra Pradesh
CDL
Kolkata
27.
Sodium Valproate Tablets I.P. 200 mg
B. No.: T2282
Mfg dt: 08/2022
Exp dt: 07/2024
Mfd by: M/s. Bharat Parenterals Ltd., Survey No. 144 & 146, Jarod Samlaya Road Tal. Savli City, Haripura, Vadodara, Gujarat – 391 520.
Related Substances
CDSCO
Zonal Office Ahmedabad
CDL
Kolkata
28.
Sodium Valproate Tablets I.P. 200 mg
B. No.: T2283
Mfg dt: 08/2022
Exp dt: 07/2024
Mfd by: M/s. Bharat Parenterals Ltd., Survey No. 144 & 146, Jarod Samlaya Road Tal. Savli City, Haripura, Vadodara, Gujarat – 391 520.
Related Substances
CDSCO
Zonal Office Ahmedabad
CDL
Kolkata
29.
Paracetamol Tablets I.P. 500 mg
B. No.: 9717
Mfg dt: 03/2021
Exp dt: 02/2024
Mfd by: M/s. Orissa Drugs & Chemicals Limited, 1, Mancheswar Industrial Estate, Bhubaneswar (Odisha).
Dissolution
CDSCO
East Zone Kolkata
CDL
Kolkata
30.
RamiRav Tablets (Ramipril Tablets
I.P. 1.25 mg)
B. No.: NKT22116A
Mfg dt: 05/2022
Exp dt: 04/2024
Mfd by: M/s. Nexkem Biotech Pvt. Ltd., Plot No. 64, HPSIDC, Industrial Area, Baddi, Distt. Solan Himachal Pradesh – 173 205.
Dissolution &
Assay
CDSCO
East Zone Kolkata
CDL
Kolkata
31.
Ridtas – S
(S(-)Amlodipine Tablets I.P.)
B. No.: RT220619
Mfg dt: 08/2022
Exp dt: 07/2024
Mfd by: M/s. Ridley Life Sciences Pvt. Ltd., D- 1651, DSIDC, Indl. Complex, Narela, Delhi – 110040.
Dissolution &
Assay
CDSCO
East Zone Kolkata
CDL
Kolkata
32.
Fenosky - 200 (Fenofibrate Tablets
I.P. 200 mg)
B. No.: T220209
Mfg dt: 02/2022
Exp dt: 01/2024
Mfd by: M/s. Medisky Pharmaceuticals, Plot No. 260, GIDC, Talod – 383215, Dist. Sabarkantha (Gujarat).
Dissolution
CDSCO
East Zone Kolkata
CDL
Kolkata
33.
Prednisolone Tablets I.P. 5 mg
B. No.: PNT5-22-221
Mfg dt: 04/2022
Exp dt: 03/2024
Mfd by: M/s. Ornate Labs Pvt. Ltd., Bela Industrial Estate, Muzaffarpur-842005. Bihar.
Description
CDSCO
East Zone Kolkata
CDL
Kolkata
34.
Prednisolone Tablets I.P. 10 mg
B. No.: PNT10-22-221
Mfg dt: 04/2022
Exp dt: 03/2024
Mfd by: M/s. Ornate Labs Pvt. Ltd., Bela Industrial Estate, Muzaffarpur-842005, Bihar.
Description
CDSCO
East Zone Kolkata
CDL
Kolkata
35.
Atorvadoc 20 (Atorvastatin Tablets I.P. 20 mg)
B. No.: MFT720
Mfg dt: 06/2022
Exp dt: 05/2024
Mfd by: M/s. Amster Labs, Unit-II, Hilltop, Ind. Estate, Vill. Bhatauli Kalan, Baddi, Distt. Solan Himachal Pradesh.
Dissolution
CDSCO
East Zone Kolkata
CDL
Kolkata
36.
Telmistad – 40 (Telmisartan Tablets IP 40 mg)
B. No.: C23D7
Mfg dt: 07/2022
Exp dt: 06/2024
Mfd by: M/s. Statmed Private Limited, 15, Jawpore Road, Kolkata – 700074.
Description
CDSCO
East Zone Kolkata
CDL
Kolkata
37.
Astyfer XT (Ferrous Ascorbate with Aminoacids, Zinc and Vitamins Tablet I.P.)
B. No.: TTQ2P5
Mfg dt: 08/2022
Exp dt: 07/2024
Mfd by: M/s. Tablets (India) Limited, 179, T.H. Road, Chennai – 600 081.
Disintegration
CDSCO
Sub-Zone Guwahati
CDL
Kolkata
38.
MYLOMAX
(Methylcobalamin, Alpha Lipoic Acid, Folic Acid, Pyridoxine Hydrochloride & Vitamin D3 Tablets)
B. No.: R2295307G
Mfg dt: 07/2022
Exp dt: 12/2023
Mfd by: M/s. Reltsen Health Care, Spl. Plot No. 9-11, PIPDIC Electronic Park, Thirubuvanai, Puducherry – 605 107.
Assay of Alpha Lipoic Acid
CDSCO
South Zone Chennai
CDL
Kolkata
39.
MECOBROOK-AT
(Methylcobalamin, Alpha Lipoic Acid,
Folic Acid, Pyridoxine Hydrochloride & Vitamin D3 Tablets)
B. No.: T2205148
Mfg dt: 05/2022
Exp dt: 04/2024
Mfd by: M/s. Healing Pharma India Pvt. Ltd., Mfg At. 81/10, GIDC, Near Vadsar Bridge, Makarpura, Vadodara - 10, Gujarat.
Disintegration, Assay of Alpha Lipoic Acid & Vitamin D3
CDSCO
South Zone Chennai
CDL
Kolkata
40.
Paracetamol Tablets I.P. 500 mg
B. No.: 220124
Mfg dt: 01/2022
Exp dt: 12/2024
Mfd by: M/s. Modi Antibiotics, Plot No. 28, G.I.D.C., Ahmedabad 382 415, Gujarat.
Dissolution
CDSCO
West Zone Mumbai
CDL
Kolkata
41.
CSP (Cough Syrup for Throat & Chesty Coughs) 100 ml
B. No.: LOCG21-85
Mfg dt: 08/2021
Exp dt: 07/2024
Mfd by: M/s. Maiden Pharmaceuticals, Village Manpura, Tehsil Nalagarh, Distt. Solan, Himachal Pradesh, Nalagarh – 174101.
Assay of Diphenhydramine Hydrochloride, Codeine Phosphate, Sodium Citrate & Menthol
Drug Control Department Himachal Pradesh
CDL
Kolkata
42.
CSP (Cough Syrup for Throat & Chesty Coughs) 100 ml
B. No.: LOCG21-94
Mfg dt: 08/2021
Exp dt: 07/2024
Mfd by: M/s. Maiden Pharmaceuticals, Village Manpura, Tehsil Nalagarh, Distt. Solan, Himachal Pradesh, Nalagarh – 174101.
Assay of Diphenhydramine Hydrochloride, Codeine Phosphate, Sodium Citrate & Menthol
Drug Control Department Himachal Pradesh
CDL
Kolkata
43.
CSP (Cough Syrup for Throat & Chesty Coughs) 100 ml
B. No.: LOCG21-95
Mfg dt: 08/2021
Exp dt: 07/2024
Mfd by: M/s. Maiden Pharmaceuticals, Village Manpura, Tehsil Nalagarh, Distt. Solan, Himachal Pradesh, Nalagarh – 174101.
Assay of Diphenhydramine Hydrochloride, Codeine Phosphate, Sodium Citrate & Menthol
Drug Control Department Himachal Pradesh
CDL
Kolkata
44.
CSP (Cough Syrup for Throat & Chesty Coughs) 100 ml
B. No.: LOCG21-84
Mfg dt: 08/2021
Exp dt: 07/2024
Mfd by: M/s. Maiden Pharmaceuticals, Village Manpura, Tehsil Nalagarh, Distt. Solan, Himachal Pradesh, Nalagarh – 174101.
Assay of Codeine Phosphate
& Menthol
Drug Control Department Himachal Pradesh
CDL
Kolkata
45.
CSP (Cough Syrup for Throat & Chesty Coughs) 100 ml
B. No.: LOCG21-96
Mfg dt: 08/2021
Exp dt: 07/2024
Mfd by: M/s. Maiden Pharmaceuticals, Village Manpura, Tehsil Nalagarh, Distt. Solan, Himachal Pradesh, Nalagarh – 174101.
Assay of Codeine Phosphate, Sodium Citrate & Menthol
Drug Control Department Himachal Pradesh
CDL
Kolkata
46.
Orthorium - MSM (Diacerein, Glucosamine Sulphate & Methyl Sulfonyl Methane Tablets)
B. No.: Not Mentioned
Mfg dt: Not Mentioned,
Exp dt: Not Mentioned
Mfd by: M/s. L.V. Life Sciences, VPO, Gurumajra, Baddi, Distt. Solan Himachal Pradesh – 174 101.
Description and Misbranded
Drug Control Department Himachal Pradesh
CDL
Kolkata
47.
RL 500 ml,
Compound Sodium Lactate Injection IP (Ringer Lactate Solution for Injection I.P.)
B. No.: S2FBV28
Mfg dt: 02/2022
Exp dt: 01/2024
Mfd by: M/s. Swaroop Pharmaceuticals Pvt. Ltd., A-10, Tala Nagari Industrial Area, Aligarh – 202 001, Uttar Pradesh.
Bacterial Endotoxins &
Sterility
Drug Control Department Odisha
CDL
Kolkata
48.
RL 500 ml,
Compound Sodium Lactate Injection IP (Ringer Lactate Solution for Injection I.P.)
B. No.: 203124
Mfg dt: 03/2022
Exp dt: 02/2024
Mfd by: M/s. Ives Drugs (India) Pvt. Ltd., Works: Ghatabillod, Distt. Dhar H.O. 504, Chetak Center, R.N.T. Marg, Indore -1 (India).
Bacterial Endotoxins &
Sterility
Drug Control Department Odisha
CDL
Kolkata
49.
RL 500 ml,
Compound Sodium Lactate Injection IP (Ringer Lactate
Solution for Injection I.P.)
B. No.: 203121
Mfg dt: 03/2022
Exp dt: 02/2024
Mfd by: M/s. Ives Drugs (India) Pvt. Ltd., Works: Ghatabillod, Distt. Dhar. H.O. 504, Chetak Center, R.N.T. Marg, Indore -1 (India).
Sterility
Drug Control Department Odisha
CDL
Kolkata
50.
RL 500 ml,
Compound Sodium Lactate Injection IP (Ringer Lactate Solution for Injection I.P.)
B. No.: 110051
Mfg dt: 10/2021
Exp dt: 09/2023
Mfd by: M/s. Ives Drugs (India) Pvt. Ltd., Works: Ghatabillod, Distt. Dhar H.O. 504, Chetak Center, R.N.T. Marg, Indore -1 (India).
Description, Particulate Contamination &
Sterility
Drug Control Department Odisha
CDL
Kolkata
51.
RL 500 ml,
Compound Sodium Lactate Injection IP (Ringer Lactate Solution for Injection I.P.)
B. No.: 204002
Mfg dt: 04/2022
Exp dt: 03/2024
Mfd by: M/s. Ives Drugs (India) Pvt. Ltd., Works: Ghatabillod, Distt. Dhar H.O. 504, Chetak Center, R.N.T. Marg, Indore -1 (India).
Sterility
Drug Control Department Odisha
CDL
Kolkata
52.
RL 500 ml,
Compound Sodium Lactate Injection IP (Ringer Lactate Solution for Inj.)
B. No.: S2FBV20
Mfg dt: 02/2022
Exp dt: 01/2024
Mfd by: M/s. Swaroop Pharmaceuticals Pvt. Ltd., A-10, Tala Nagari Industrial Area, Aligarh – 202 001, Uttar Pradesh.
Bacterial Endotoxins
Drug Control Department Odisha
CDL
Kolkata
53.
RL 500 ml,
Compound Sodium Lactate Injection I.P. (Ringer Lactate Solution for Injection I.P.)
B. No.: 203119
Mfg dt: 03/2022
Exp dt: 02/2024
Mfd by: M/s. Ives Drugs (India) Pvt. Ltd., Works: Ghatabillod, Distt. Dhar H.O. 504, Chetak Center, R.N.T. Marg, Indore -1 (India).
Particulate Contamination &
Sterility
Drug Control Department Odisha
CDL
Kolkata
54.
RL 500 ml,
Compound Sodium Lactate Injection I.P.
(Ringer Lactate Solution for Injection I.P.)
B. No.: 112085
Mfg dt: 12/2021
Exp dt: 11/2023
Mfd by: M/s. Ives Drugs (India) Pvt. Ltd., Works: Ghatabillod, Distt. Dhar H.O. 504, Chetak Center, R.N.T. Marg, Indore -1 (India).
Sterility
Drug Control Department Odisha
CDL
Kolkata
55.
RL 500 ml,
Compound Sodium Lactate Injection I.P. (Ringer Lactate Solution for Injection I.P.)
B. No.: 203047
Mfg dt: 03/2022
Exp dt: 02/2024
Mfd by: M/s. Ives Drugs (India) Pvt. Ltd., Works: Ghatabillod, Distt. Dhar H.O. 504, Chetak Center, R.N.T. Marg, Indore -1 (India).
Sterility
Drug Control Department Cuttack
CDL
Kolkata
56.
RL 500 ml,
Compound Sodium Lactate Injection IP (Ringer Lactate Solution for Injection)
B. No.: S2FBV38
Mfg dt: 02/2022
Exp dt: 01/2024
Mfd by: M/s. Swaroop Pharmaceuticals Pvt. Ltd., A-10, Tala Nagari Industrial Area, Aligarh – 202 001 Uttar Pradesh.
Bacterial Endotoxins
Drug Control Department Cuttack
CDL
Kolkata
57.
Ampholis Injection – 10 ml (Amphotericin B Emulsion Injection)
B. No.: SI-515
Mfg dt: 06/2021
Exp dt: 05/2023
Mfd by: M/s. Shivam Enterprises, Suketi Road, Kala-Amb, Distt. Sirmour Himachal Pradesh – 173 030.
pH, Bacterial endotoxins and Sterility
Drug Control Department Rajasthan
CDL
Kolkata
58.
Zinc Sulphate Dispersible Tablets IP 20 mg
B. No.: ZST903
Mfg dt: 01/2022
Exp dt: 12/2023
Mfd by: M/s. Unicure India Ltd.,C-21, 22 & 23, Sector -3, Noida – 201301, Distt. Gautam Budh Nagar, Uttar
Pradesh.
Assay
CDSCO
Subzone Bangalore
CDTL
Chennai
59.
Metronidazole Tablets IP 400 mg
B. No.: 3000521
Mfg dt: 03/2021 Exp dt: 02/2024
Mfd by: M/s. Karnataka Antibiotics and Pharmaceuticals Ltd., Plot No.14, II Phase, Peenya, Bengaluru- 560058.
Dissolution
CDSCO
Subzone Bangalore
CDTL
Chennai
60.
Junior Lanzol 15 mg (Lansoprazole Orally Disintegrating Tablets 15 mg)
B. No.: BA12571
Mfg dt: 08/2021
Exp dt: 07/2023
Mfd by: M/s. Cipla Ltd., Malpur, Dist. Solan 173205, Himachal Pradesh.
Hardness
CDSCO
Sub-Zone Indore
CDTL
Mumbai
61.
Decmax 4 mg (Dexmethasone Tablets IP 4 mg)
B. No.: ST-21286
Mfg dt: 06/2021
Exp dt: 05/2024
Mfd by: M/s. Supermax Drugs & Pharmaceutical Pvt. Ltd., (Unit-II, Khasra No. 322, Nanheda Anantpur, Bhagwanpur, Roorkee- 247668, Haridwar, Uttarakhand.
Related substances.
CDSCO
West- Zone Mumbai
CDTL
Mumbai
62.
FERROUS ASCORBATE & FOLIC ACID CAPSULES
B. No.: 1013
Mfg dt: 12/2021
Exp dt: 11/2023
Mfd by: M/s. Vivimed Labs Limited, D-125 & 128, Phase III, I.D.A., Jeedimetla, Medchal- Malkajgiri (Dist) Telangana State- 500055.
AVERAGE FILL AND ASSAY FOLIC ACID
CDSCO
Zonal office Hyderabad
CDTL
Hyderabad
63.
Ceftriaxone and Sulbactam for Injection (Metifex SL 1500 Injection)
B. No.: 322-797
Mfg dt: 08/2022
Exp dt: 07/2024
Mfd by: M/s. Zee Laboratories Limited Behind 47, Industrial Area, Paonta Sahib- 173205, Himachal Pradesh.
Identification of Ceftriaxone Sodium and Sulbcatam Sodium, pH and Assay of Ceftriaxone Sodium calculated as Ceftriaxone and Sulbactam Sodium
calculated as Sulbactam
CDSCO
Sub-Zone Baddi
RDTL
Chandigarh
64.
Ramipril Tablets IP (Ramichek 5 Tablets)
B. No.: MT214919
Mfg dt: 11/2021
Exp dt: 10/2023
Mfd by: M/s. Mascot Health Series Pvt. Ltd., Plot No. 79,80, Sector- 6A, IIE, Sidcul, Haridwar-249403, Uttarakhand.
Assay and Dissolution of Ramipril Tablets IP (Ramichek 5 Tablets)
CDSCO
Sub-Zone Baddi
RDTL
Chandigarh
65.
Paediatric Paracetamol Oral Suspension BP (PARA 120 SUSPENSION)
B. No.: D10086
Mfg dt: 10/2021
Exp dt: 09/2024
Mfd by: M/s. DM PHARMA PVT. LTD., Vill-Bhud, NH-21A, Baddi, Distt - Solan, Himachal Pradesh- 173205, INDIA.
Related Substances and Assay of Paracetamol
CDSCO
Sub-Zone Baddi
RDTL
Chandigarh
66.
Paediatric Paracetamol Oral Suspension BP (PARA 120 SUSPENSION)
B. No.: D10085
Mfg dt: 10/2021
Exp dt: 09/2024 Mfd by: M/s. DM PHARMA PVT. LTD., Vill-Bhud, NH-21A, Baddi, Distt-Solan, Himachal Pradesh - 173205, INDIA.
Related Substances and Assay of Paracetamol
CDSCO
Sub-Zone Baddi
RDTL
Chandigarh
67.
Betamethasone and Clioquinol Cream BP (BETNOVATE-C SKIN CREAM)
B. No.: NH1118
Mfg dt: 01/2021
Exp dt: 12/2022
Mfd by: M/s. GlaxoSmithKline Pharmaceuticals Limited, At. A-10, M.I.D.C., Ambad- Pathardi Block, Nashik 422010, Maharashtra, INDIA.
Identification (A), (B), (C) and Assay of Betamethasone Valerate calculated as Betamethasone and Clioquinol
Drug Control Department Delhi
RDTL
Chandigarh
*Remark: The firm M/s. GSK notified this office regarding availability of Spurious/ Counterfeit of the said batch of drug.
Investigation is under process.
68.
Telmisartan and Hydrochlorothiazide Tablets IP (SARTAN-H TABLETS)
B. No.: 012259
Mfg dt: 01/2022
Exp dt: 12/2023
Mfd by: M/s. Biolgics Inc., Suketi Road, Kala- Amb, Distt. Sirmour, Himachal Pradesh - 173030
Dissolution of Telmisartan
Drug Control Department Ladakh
RDTL
Chandigarh
69.
Hydroquinone, Tretinoin and Mometasone Furoate Cream (Melamet Cream)
B. No.: A191070
Mfg dt: 12/2020
Exp dt: 01/2023
Mfd by: M/s. Universal Twin Labs, Village Gullarwala, Near Sai Road, Baddi, Dist.- Solan, Himachal Pradesh.
pH, Identification and Assay of Hydroquinone, Tretinoin and Mometasone Furoate
Drug Control Department Delhi
RDTL
Chandigarh
70.
Steptococcus Faecalis, Clostridium Butyricum, Bacillus mesentericus and Lactic Acid Bacillus Capsules
B. No.: CHC-1054
Mfg dt: 11/2021
Exp dt: 10/2023
Mfd by: M/s. Cotec Healthcare Pvt. Ltd., NH. No.74, Roorkee- Dehradun Highway, Kishanpur, Roorkee- 247667 Haridwar (Uttrakhand).
Identification and Assay of Streptococcus faecalis
CDSCO
North Zone
RDTL
Chandigarh
For more details, check out the official notice below:
2 years 2 months ago
News,Industry,Pharma News,Top Industry News